Skip to content

Clinical trials

Phase 3 Stroke trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stroke Phase: Phase 3 Country / region: Brazil Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20052
20062
20071
20081
20093
20101
20111
20121
20134
20143
20151
20161
20172
20183
20192
20201
20212
20221
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Terminated7
Recruiting5
Active, not recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
AstraZeneca3
Bayer3
Boehringer Ingelheim2
Hospital Moinhos de Vento2
Hospital de Clinicas de Porto Alegre2
Janssen Research & Development, LLC2
Pfizer2
Population Health Research Institute2
Sanofi2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stroke36
Myocardial Infarction12
Cardiovascular Diseases9
Atrial Fibrillation8
Ischemic Stroke6
Coronary Artery Disease4
Heart Diseases4
Ischemic Attack, Transient4
Acute Coronary Syndrome3
Heart Failure3

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.